Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians.

J Ophthalmol · 2012 · PMC3246783 · PMID 22220269

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

An interim analysis from the SAILOR (Safety Assessment of Intravitreal Lucentis for AMD) study showed a trend for an increase in the incidence of stroke in the group treated with 0.5 mg of ranibizumab [ 82 , 83 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.